This is a list of Phase 3 trials with primary completion dates in April 2026 for companies with a market cap less than $1B. For complete clinical trial coverage, please see our Trial Tracker tool.
This is a list of Phase 3 trials with primary completion dates in April 2026 for companies with a market cap less than $1B. For complete clinical trial coverage, please see our Trial Tracker tool.